Week Ending: 28 August 2026

India IN Sector

Healthcare

For the week ending 28 August 2026, Healthcare advanced 2.08% with 92 advancing, 68 declining, and 1 unchanged constituents. The index is equal weighted and built from country-listed equities.

Current architecture Upward Expansion

The activity fan is positively ordered above a rising Trend Line with price accepted above it.

80 technical evidence
Index5427.85 1 week2.08% Breadth57% Members161
Country 🇮🇳 India · IN
Universe country-listed
Price basis Adjusted weekly close

Trend architecture

Index, activity fan and structural anchors

Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.

Index Value Trend Line Fair Value Activity Lines Constructive architecture Transitional architecture Defensive architecture
Current architecture Upward Expansion 13 completed weeks in this state
Trend acceptance 15.9% Index versus Trend Line
Persistence 100% Positive across every horizon
Participation 57% 92 advancing, 68 declining

Investor positioning lens

Is the evidence ready for capital?

A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.

Current posture Positioning window open

Trend, participation and relative evidence are sufficiently aligned for selective exposure.

80 technical evidence
out of 100
Evidence balance

Five-pillar map

Position
Trend
89
Breadth
61
Persistence
70
Relative
100
Risk quality
93
What supports the view
  • The index remains above a constructive Trend gate.
  • Participation is broad enough to support the index move.
  • Constituent trends show positive multi-horizon persistence.
  • Relative performance is improving within its parent hierarchy.
What restrains conviction
  • The index is extended well above current Fair Value, increasing chase risk.
Independent sentiment overlay Sentiment held separate

Qualified news coverage is too thin to alter the technical positioning view.

Evidence that would change the view
  1. A completed weekly close below the Trend Line at 4,681.47 would weaken the constructive case.
  2. Breadth falling below 45% while the index holds up would signal narrowing leadership.
  3. A turn to negative 13 and 26-week parent-relative performance would remove the rotation edge.

This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.

Trend state and durability

Architecture, persistence and constituent regimes

The index path is tested against the underlying security-level trend evidence.

Index architecture Upward Expansion

The activity fan is positively ordered above a rising Trend Line with price accepted above it.

State age13 weeks
Trend gateUp
Fan width7.50%
Fast versus slow change-0.55 pts
Above 83% Below 0%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence

Positive across every horizon

100% agreement

The 13, 26, 39 and 52-week trends all point upward, giving the advance broad horizon agreement.

13-week
12.9%
26-week
28.3%
39-week
18.4%
52-week
18.9%
Regime age21 weeks 52-week flips13 52-week boundary4565.24
Constituent trend persistence

Is the index move broadly durable?

93% coverage
Coherent positive42%
Coherent negative13%
Average horizon agreement83%
Positive horizon share68%
Weakening positives15
Repairing negatives24

150 constituents measured as of 28 Aug 2026. Median trend age is 18 weeks.

Custom stage map

Where constituents sit in the cycle

91% coverage
Stage 1 · Basing16%24 securities
Stage 2 · Advancing58%85 securities
Stage 3 · Distribution5%7 securities
Stage 4 · Declining21%31 securities
Re-acceleration watch0 Transition watch18 Relative strength leaders48% Fair Value repairs18

Measured as of 28 Aug 2026. Stages summarize price, Activity Line architecture, Fair Value position and relative evidence.

Architecture breadth

How market energy is distributed

78/100 mean confidence
Upward expansion
53% 78
Rotation up
3% 4
Deceleration
18% 26
Balance
12% 17
Rotation down
6% 9
Downward expansion
9% 13
Unresolved
0% 0

Architecture breadth shows the distribution of expanding, rotating, balancing and contracting securities. It is diagnostic context and is not added as a second vote in the positioning score.

Capital rotation

Performance relative to IN Market Structure

Improving
Relative index 13-week relative trend Starting level
Rotation dashboard Improving

A rising relative line means this group is compounding faster than IN Market Structure. A falling line means capital has done better in the parent benchmark.

Relative index130.5
13-week trend126.4
4-week trend change2.05%
Weekly peer rank1 of 11
1 week
1.5 pts relative
4 weeks
2.6 pts relative
13 weeks
6.9 pts relative
26 weeks
15.4 pts relative
52 weeks
16.9 pts relative

Market internals

Participation, dispersion and path risk

Equal-weight index evidence with constituent-level breadth and dispersion.

Breadth

Participation quality

Broad
Advancing
92
Declining
68
Unchanged
1
4-week average 51%
13-week average 51%
Risk and persistence

Path quality

52-week lens
Annualised weekly volatility15.1%
Drawdown from 52-week high0.0%
Positive weeks, last 1385%
Current directional run5 weeks
Turnover versus 13-week norm253%
Breadth impulse6.4 pts
Cross-section

Return distribution

161 measured
Q1 -1.7% Median 0.7% Q3 4.4%
Average winner5.9%
Average loser-2.8%
Dispersion6.7 pts
Top-five upside share23%
Top-five capital share30%
Capital data coverage100%

Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.

Momentum cycle

30-week persistence

Positive readings show expansion. Negative readings show contraction.

Breadth cycle

Net participation

Advancers less decliners as a percentage of measured constituents.

Industry map

Where sector leadership is forming

Performance, breadth and trend acceptance across every qualified industry.

6/8 positive
Above Trend Line8/8100% of industries
Constructive breadth6/8At least half advancing
Median industry1.40%1.68 pts dispersion
#1 Advancing

Drug Manufacturers - Specialty & Generic

3.07%
Participation59% vs Trend19.6% vs Fair Value26.5% Members91
#2 Advancing

Health Information Services

2.14%
Participation75% vs Trend8.3% vs Fair Value5.1% Members4
#3 Advancing

Medical Care Facilities

2.03%
Participation64% vs Trend8.6% vs Fair Value34.6% Members22
#4 Advancing

Medical Devices

1.48%
Participation67% vs Trend10.8% vs Fair Value2.5% Members3
#5 Advancing

Diagnostics & Research

1.32%
Participation67% vs Trend17.9% vs Fair Value35.4% Members9
#6 Transition

Drug Manufacturers - General

0.31%
Participation45% vs Trend18.9% vs Fair Value38.3% Members11
#7 Weakening

Medical Instruments & Supplies

-0.93%
Participation60% vs Trend17.2% vs Fair Value0.0% Members5
#8 Narrowing

Biotechnology

-2.40%
Participation33% vs Trend3.0% vs Fair Value22.9% Members12

News and narrative

Does company news confirm the market tape?

Open Sentiment Intelligence
Sentiment evidence is still developing

Qualified company-level news coverage is not yet broad enough to influence the group view.

1 qualified records across 161 measured constituents.

Leadership tape

Leaders, laggards and contribution shape

Latest completed week, ranked on uncapped constituent returns.

Leading edge

1 NATCAPSUQNatural Capsules Limited
34.95% 2 ENTEROEntero Healthcare Solutions Limited
27.04% 3 SYNCOMFSyncom Formulations (India) Limited
20.57% 4 BAFNAPHBafna Pharmaceuticals Limited
20.07% 5 NECLIFENectar Lifesciences Limited
19.10%

Weakest edge

161 TAKETAKE Solutions Limited
-22.52% 160 MEDIASSISTMEDI ASSIST HEALTH SER L
-7.47% 159 VENUSREMVenus Remedies Limited
-6.41% 158 ORTINGLOBEOrtin Global Limited
-6.04% 157 CONCORDBIOConcord Biotech Limited
-5.74%

Constituent ledger

Sector constituents

Top 100 of 161 shown, ranked by latest weekly return.

Rank Ticker Company Exchange Market cap Close Index contribution Return
1 NATCAPSUQ Natural Capsules Limited NSI 1.88B 204.96 0.16 pts
34.95%
2 ENTERO Entero Healthcare Solutions Limited NSI 71.73B 1,808.60 0.16 pts
27.04%
3 SYNCOMF Syncom Formulations (India) Limited NSI 16.01B 19.46 0.13 pts
20.57%
4 BAFNAPH Bafna Pharmaceuticals Limited NSI 6.64B 291.10 0.12 pts
20.07%
5 NECLIFE Nectar Lifesciences Limited NSI 2.42B 12.47 0.12 pts
19.10%
6 THEMISMED Themis Medicare Limited NSI 11.73B 125.48 0.11 pts
18.22%
7 BROOKS Brooks Laboratories Limited NSI 1.86B 69.28 0.10 pts
15.47%
8 MANGALAM Mangalam Drugs & Organics Limited NSI 497.17M 31.94 0.10 pts
15.39%
9 IOLCP IOL Chemicals and Pharmaceuticals Limited NSI 54.60B 194.95 0.09 pts
15.00%
10 VIVIMEDLAB Vivimed Labs Limited NSI 564.64M 7.07 0.08 pts
13.30%
11 YATHARTH Yatharth Hospital & Trauma Care Services Limited NSI 93.01B 967.40 0.08 pts
13.13%
12 AHCL ANLON HEALTHCARE LIMITED NSI 8.05B 15.91 0.07 pts
11.41%
13 SHILPAMED Shilpa Medicare Limited NSI 168.35B 903.80 0.07 pts
10.90%
14 MOREPENLAB Morepen Laboratories Limited NSI 53.14B 106.37 0.07 pts
10.79%
15 KREBSBIO Krebs Biochemicals & Industries Limited NSI 1.14B 59.17 0.06 pts
10.37%
16 SIGACHI Sigachi Industries Limited NSI 12.87B 33.13 0.06 pts
10.25%
17 INDOCO Indoco Remedies Limited NSI 22.02B 248.80 0.06 pts
9.95%
18 ANUHPHR Anuh Pharma Limited NSI 7.84B 83.57 0.06 pts
9.92%
19 AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited NSI 2.69B 89.01 0.06 pts
9.62%
20 INDSWFTLAB Ind-Swift Laboratories Limited NSI 31.96B 361.00 0.06 pts
9.53%
21 GAUDIUMIVF GAUDIUM IVF N WOMEN H L NSI 8.52B 121.72 0.06 pts
9.25%
22 BIOFILCHEM Biofil Chemicals and Pharmaceuticals Limited NSI 515.39M 32.93 0.05 pts
8.82%
23 GLENMARK Glenmark Pharmaceuticals Limited NSI 688.15B 2,515.00 0.05 pts
8.50%
24 NURECA Nureca Limited NSI 3.05B 331.05 0.05 pts
7.94%
25 MANIPALHOS Manipal Health Enterprises Limited NSI 1.02T 771.65 0.05 pts
7.88%
26 GUJTHEM Gujarat Themis Biosyn Limited NSI 45.93B 411.05 0.05 pts
7.83%
27 LAURUSLABS Laurus Labs Limited NSI 1.02T 1,938.50 0.05 pts
7.57%
28 UNICHEMLAB Unichem Laboratories Limited NSI 37.34B 565.95 0.05 pts
7.56%
29 DIVISLAB Divi's Laboratories Limited NSI 2.40T 9,239.00 0.05 pts
7.47%
30 GLAXO GlaxoSmithKline Pharmaceuticals Limited NSI 514.05B 3,106.40 0.04 pts
7.04%
31 SAGILITY Sagility Limited NSI 205.98B 46.34 0.04 pts
6.90%
32 NH Narayana Hrudayalaya Limited NSI 382.38B 1,932.10 0.04 pts
6.40%
33 ZYDUSLIFE Zydus Lifesciences Limited NSI 1.15T 1,191.00 0.04 pts
6.34%
34 PARKHOSPS PARK MEDI WORLD LIMITED NSI 124.91B 290.80 0.04 pts
5.92%
35 KILITCH Kilitch Drugs (India) Limited NSI 5.99B 171.77 0.04 pts
5.82%
36 SPARC Sun Pharma Advanced Research Company Limited NSI 63.07B 208.00 0.04 pts
5.74%
37 METROPOLIS Metropolis Healthcare Limited NSI 118.27B 588.45 0.04 pts
5.66%
38 RUBICON RUBICON RESEARCH LIMITED NSI 300.27B 1,815.00 0.03 pts
5.24%
39 GKSL GUJARAT KIDNEY N SUP SP L NSI 12.01B 160.50 0.03 pts
4.92%
40 WOCKPHARMA Wockhardt Limited NSI 305.83B 1,975.00 0.03 pts
4.70%
41 SURAKSHA SURAKSHA DIAGNOSTIC LTD NSI 17.64B 340.20 0.03 pts
4.42%
42 MEDANTA Global Health Limited NSI 392.03B 1,469.50 0.03 pts
4.24%
43 VALIANTLAB Valiant Laboratories Limited NSI 5.86B 99.65 0.03 pts
4.08%
44 VAISHALI Vaishali Pharma Limited NSI 1.07B 8.31 0.02 pts
4.01%
45 ALBERTDAVD Albert David Limited NSI 4.97B 898.60 0.02 pts
3.99%
46 THYROCARE Thyrocare Technologies Limited NSI 96.32B 587.50 0.02 pts
3.88%
47 SUDEEPPHRM SUDEEP PHARMA LIMITED NSI 127.53B 1,152.10 0.02 pts
3.62%
48 ANTHEM ANTHEM BIOSCIENCES LTD NSI 509.98B 900.10 0.02 pts
3.29%
49 STAR Strides Pharma Science Limited NSI 90.60B 1,018.40 0.02 pts
3.27%
50 AARTIPHARM Aarti Pharmalabs Limited NSI 76.28B 843.00 0.02 pts
3.21%
51 TORNTPHARM Torrent Pharmaceuticals Limited NSI 1.86T 5,050.00 0.02 pts
3.13%
52 AKUMS AKUMS DRUGS AND PHARMA L NSI 116.97B 772.60 0.02 pts
3.01%
53 KOPRAN Kopran Limited NSI 9.39B 201.76 0.02 pts
2.89%
54 TTKHLTCARE TTK Healthcare Limited NSI 15.41B 1,134.20 0.02 pts
2.88%
55 MARKSANS Marksans Pharma Limited NSI 150.02B 329.55 0.02 pts
2.57%
56 INDGN INDEGENE LIMITED NSI 137.19B 582.00 0.02 pts
2.50%
57 GLAND Gland Pharma Limited NSI 478.93B 2,888.00 0.02 pts
2.44%
58 PPLPHARMA Piramal Pharma Limited NSI 279.96B 218.68 0.01 pts
2.34%
59 FORTIS Fortis Healthcare Limited NSI 689.92B 926.75 0.01 pts
2.17%
60 HALEOSLABS Haleos Labs Limited NSI 4.54B 1,495.10 0.01 pts
2.05%
61 IPCALAB Ipca Laboratories Limited NSI 495.33B 1,950.30 0.01 pts
2.05%
62 LALPATHLAB Dr. Lal PathLabs Limited NSI 323.49B 1,931.10 0.01 pts
1.95%
63 SAILIFE SAI LIFE SCIENCES LIMITED NSI 310.19B 1,485.00 0.01 pts
1.89%
64 MEDICAMEQ Medicamen Biotech Limited NSI 3.26B 248.88 0.01 pts
1.77%
65 APOLLOHOSP Apollo Hospitals Enterprise Limited NSI 1.27T 8,838.50 0.01 pts
1.67%
66 ALPA Alpa Laboratories Limited NSI 1.30B 63.77 0.01 pts
1.63%
67 LYKALABS Lyka Labs Limited NSI 2.69B 74.80 0.01 pts
1.60%
68 BLISSGVS Bliss GVS Pharma Limited NSI 60.05B 588.10 0.01 pts
1.55%
69 AUROPHARMA Aurobindo Pharma Limited NSI 935.45B 1,645.30 0.01 pts
1.48%
70 JSLL JEENA SIKHO LIFECARE LTD NSI 63.92B 512.50 0.01 pts
1.41%
71 MAXHEALTH Max Healthcare Institute Limited NSI 978.14B 1,014.10 0.01 pts
1.41%
72 UNIVPHOTO Universus Photo Imagings Limited NSI 4.93B 456.05 0.01 pts
1.33%
73 SHALBY Shalby Limited NSI 16.84B 154.96 0.01 pts
1.31%
74 SOLARA Solara Active Pharma Sciences Limited NSI 29.79B 623.70 0.01 pts
1.10%
75 JAGSNPHARM Jagsonpal Pharmaceuticals Limited NSI 15.97B 239.06 0.01 pts
1.07%
76 POLYMED Poly Medicure Limited NSI 173.45B 1,733.00 0.01 pts
1.00%
77 LAXMIDENTL LAXMI DENTAL LIMITED NSI 10.80B 200.00 0.01 pts
0.94%
78 AGARWALEYE DR AGARWALS HEALTH CARE L NSI 158.84B 504.85 0.01 pts
0.93%
79 SUNPHARMA Sun Pharmaceutical Industries Limited NSI 4.56T 1,920.00 0.01 pts
0.93%
80 DCAL Dishman Carbogen Amcis Limited NSI 27.46B 174.77 0.00 pts
0.71%
81 RAINBOW Rainbow Children's Medicare Limited NSI 146.77B 1,442.80 0.00 pts
0.67%
82 BALAXI Balaxi Pharmaceuticals Limited NSI 1.25B 22.54 0.00 pts
0.63%
83 FABTECH FABTECH TECHNOLOGIES LTD NSI 6.53B 147.56 0.00 pts
0.50%
84 WINDLAS Windlas Biotech Limited NSI 20.19B 998.55 0.00 pts
0.50%
85 KRSNAA Krsnaa Diagnostics Limited NSI 18.35B 564.05 0.00 pts
0.43%
86 ZIMLAB ZIM Laboratories Limited NSI 6.78B 125.46 0.00 pts
0.34%
87 EMCURE EMCURE PHARMACEUTICALS L NSI 353.28B 1,869.40 0.00 pts
0.34%
88 DRREDDY Dr. Reddy's Laboratories Limited NSI 984.61B 1,178.00 0.00 pts
0.28%
89 AARTIDRUGS Aarti Drugs Limited NSI 38.24B 418.55 0.00 pts
0.28%
90 JUBLPHARMA Jubilant Pharmova Limited NSI 140.55B 882.65 0.00 pts
0.26%
91 MAXIND Max India Limited NSI 8.49B 150.40 0.00 pts
0.20%
92 LINCOLN Lincoln Pharmaceuticals Limited NSI 12.27B 614.95 0.00 pts
0.15%
93 BAJAJHCARE Bajaj HealthCare Limited NSI 10.97B 322.00 0.00 pts
0.00%
94 MANKIND Mankind Pharma Limited NSI 988.59B 2,382.90 0.00 pts
-0.05%
95 ALIVUS Alivus Life Sciences Limited NSI 167.58B 1,349.70 0.00 pts
-0.09%
96 GPTHEALTH GPT Healthcare Limited NSI 12.48B 150.50 0.00 pts
-0.09%
97 SUPRIYA Supriya Lifescience Limited NSI 62.92B 804.15 0.00 pts
-0.16%
98 ONESOURCE ONESOURCE SPECL PHARMA L NSI 170.13B 1,532.20 0.00 pts
-0.18%
99 SANOFICONR SANOFI CONS HEALTHC IND L NSI 95.91B 4,213.70 0.00 pts
-0.20%
100 ABBOTINDIA Abbott India Limited NSI 563.64B 26,175.00 0.00 pts
-0.21%

The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.

Evidence context